{"product_id":"glow-70mg-research-peptide-pure-peptides-australia","title":"GLOW","description":"\u003ch2\u003eGLOW (70mg) — Three-Peptide Skin and Tissue-Repair Research Blend\u003c\/h2\u003e\n\u003cp\u003eOmega Peptides Australia supplies GLOW (70mg) in Australia from domestic stock, dispatching same day on orders placed before 12pm with a certificate of analysis published for every batch. Often written GLOW peptide, GLOW peptides, GLOW blend or glowing peptide, it is a three-peptide blend combining GHK-Cu, BPC-157 and TB-500 in a single vial. The current batch was tested by Janoshik Analytical on 9 July 2026, with every component identified and quantified; the certificates are published before the vial ships.\u003c\/p\u003e\n\u003cp\u003eGLOW is a multi-peptide research blend that combines three separately studied peptides in one lyophilised vial: 50mg of GHK-Cu (the copper-binding tripeptide glycyl-L-histidyl-L-lysine, first isolated from human plasma in 1973), 10mg of BPC-157 (a fifteen-amino-acid pentadecapeptide derived from a protective protein in gastric juice) and 10mg of TB-500 (a synthetic peptide based on the actin-binding region of thymosin beta-4), for 70mg of peptide in total. It is often written as GLOW peptide, glow blend or glow 70, and sometimes described simply as the GHK-Cu BPC-157 TB-500 blend. The name is a coined product name that reflects the skin and collagen focus of its largest component.\u003c\/p\u003e\n\u003cp\u003eGLOW is studied in two main directions: skin and collagen remodelling, driven by GHK-Cu, and soft-tissue repair and angiogenesis, driven by BPC-157 and TB-500. At the pathway level the three components act through distinct mechanisms, from copper delivery and gene modulation in fibroblasts to growth-factor and nitric-oxide signalling in endothelial cells and regulation of the actin cytoskeleton, which is the rationale for combining them in a single research vial.\u003c\/p\u003e\n\u003cp\u003eOmega Peptides Australia supplies GLOW as a high-purity (≥99% HPLC) COA-verified lyophilised powder in a sealed sterile vial. Orders placed before 12pm are dispatched the same day from within Australia, and the Certificate of Analysis for each batch is published in our \u003ca href=\"\/pages\/certifications-of-analysis\"\u003eCOA library\u003c\/a\u003e. Researchers looking to buy the GLOW blend in Australia get verified material and domestic stock with no customs delays.\u003c\/p\u003e\n\n\u003ch2\u003eKey research areas\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkin and collagen remodelling\u003c\/strong\u003e GHK-Cu has been studied in fibroblast cultures and skin models for its effect on collagen, elastin and glycosaminoglycan synthesis, and on the balance between matrix metalloproteinases and their tissue inhibitors. It is proposed to act by delivering copper to cells, where it is a cofactor for the collagen-crosslinking enzyme lysyl oxidase, and by modulating the expression of genes involved in tissue remodelling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWound healing\u003c\/strong\u003e All three components have been investigated in wound models. GHK-Cu has been studied in dermal wound and ulcer models, full-length thymosin beta-4 has progressed through Phase 2 clinical programmes for chronic dermal wounds, and BPC-157 has been examined in rodent skin-wound and burn models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTendon, ligament and muscle repair\u003c\/strong\u003e BPC-157 and TB-500 are the most frequently paired peptides in preclinical connective-tissue research. BPC-157 is proposed to increase fibroblast outgrowth and collagen deposition through FAK-paxillin signalling, while TB-500 regulates the actin cytoskeleton that cells need in order to migrate into an injury site.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAngiogenesis\u003c\/strong\u003e New vessel formation is a shared endpoint across the blend. BPC-157 activates VEGFR2 and nitric-oxide signalling in endothelial cells, thymosin beta-4 promotes endothelial cell migration and tube formation, and GHK-Cu has been reported to increase VEGF expression in cultured cells.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHair follicle research\u003c\/strong\u003e GHK-Cu and thymosin beta-4 have each been studied in rodent hair-growth models, where the proposed mechanisms include increased follicle size, stem-cell activation and improved blood supply to the follicle.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntioxidant and anti-inflammatory signalling\u003c\/strong\u003e GHK-Cu has been studied for antioxidant effects, including supply of copper to superoxide dismutase and modulation of inflammatory cytokines, while thymosin beta-4 has been reported to reduce NF-κB activation in injured tissue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eGLOW in Australia\u003c\/h2\u003e\n\u003cp\u003eGLOW is supplied in Australia strictly as a research-grade lyophilised vial; it is not a registered medicine and is not available through Chemist Warehouse, Priceline or compounding pharmacies. Omega Peptides Australia holds it in domestic stock, dispatches same day on orders before 12pm, and ships on tracked delivery within Australia, so there is no international transit or customs hold. Each batch carries an independent certificate in the \u003ca href=\"\/pages\/certifications-of-analysis\"\u003eCOA library\u003c\/a\u003e matched to the number printed on the vial. Browse the full range of \u003ca href=\"\/\"\u003eresearch peptides in Australia\u003c\/a\u003e on our homepage.\u003c\/p\u003e\n\u003cp\u003eGLOW is stocked in Australia as a 70mg vial. Its three components, \u003ca href=\"\/products\/ghk-cu\"\u003eGHK-Cu\u003c\/a\u003e, \u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e and \u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e, are each held individually, and the four-peptide \u003ca href=\"\/products\/klow\"\u003eKLOW blend\u003c\/a\u003e adds KPV. A \u003ca href=\"\/products\/glow-bundle\"\u003eGLOW bundle\u003c\/a\u003e pairs the vial with diluent and consumables.\u003c\/p\u003e\n\n\u003ch2\u003eHow GLOW works\u003c\/h2\u003e\n\u003cp\u003eEach component of GLOW works through a different mechanism. GHK-Cu binds copper(II) with high affinity and carries it into cells, where copper is required by lysyl oxidase for collagen and elastin crosslinking and by superoxide dismutase for antioxidant defence; in fibroblast studies it also alters the expression of a large number of genes governing matrix synthesis, breakdown and repair. BPC-157 activates VEGFR2 and the Akt-eNOS pathway in endothelial cells, increasing nitric-oxide production and angiogenesis, and triggers the FAK-paxillin pathway in fibroblasts, increasing their migration and collagen output. TB-500 reproduces the Leu-Lys-Lys-Thr-Glu-Thr-Gln motif of thymosin beta-4 that binds G-actin, regulating cytoskeletal remodelling so that cells can move and divide during repair.\u003c\/p\u003e\n\u003cp\u003eGLOW is available in two forms. This 70mg single vial contains all three peptides pre-combined in fixed amounts, so one reconstitution gives a solution containing all three. The \u003ca href=\"\/products\/glow-bundle\"\u003eGLOW Peptide Bundle\u003c\/a\u003e supplies the same three peptides as separate vials, which suits studies that need each compound at its own concentration or want to run single-compound controls. For an anti-inflammatory tripeptide in the same base, the \u003ca href=\"\/products\/klow\"\u003eKLOW blend\u003c\/a\u003e adds 10mg of KPV. Human pharmacokinetic data for the individual peptides are limited, and none of the three is an approved medicine.\u003c\/p\u003e\n\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGLOW blend (GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg per vial)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAlso known as\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGLOW peptide, glow blend, glow 70, GHK-Cu BPC-157 TB-500 blend, GLOW peptides, glowing peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCAS number\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGHK-Cu 89030-95-5; BPC-157 137525-51-0; TB-500 885340-08-9 (fragment) or 77591-33-4 (full-length thymosin beta-4)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular formula\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGHK-Cu C14H22CuN6O4; BPC-157 C62H98N16O22; TB-500 fragment C38H68N10O14\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular weight\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGHK-Cu 401.9 g\/mol; BPC-157 1419.6 g\/mol; TB-500 fragment 889.0 g\/mol (full-length thymosin beta-4 4963.5 g\/mol)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSequence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGHK-Cu Gly-His-Lys (copper complex); BPC-157 GEPPPGKPADDAGLV; TB-500 Ac-LKKTETQ\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSkin \u0026amp; collagen research, tissue-repair research\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEach component tested individually by Janoshik Analytical (9 July 2026): GHK-Cu 99.89% (batch #199767), BPC-157 99.66% (batch #199765), TB-500 98.82% (batch #199784) · certificates in the \u003ca href=\"\/pages\/certifications-of-analysis\"\u003eCOA library\u003c\/a\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eForm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLyophilised powder in a sealed sterile vial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eVial sizes available\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e70mg — $139.99\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage (lyophilised)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2–8°C short term or −20°C long term, protect from light and moisture, avoid repeated freeze-thaw\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage (reconstituted)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2–8°C, use within 28 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBacteriostatic water (recommended)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAvailable sizes and pricing\u003c\/h2\u003e\n\u003cp\u003eGLOW is supplied in a single 70mg vial containing all three peptides in fixed amounts. The same three compounds are also available as separate vials in the GLOW Peptide Bundle at $189.99, and buying them individually (GHK-Cu 50mg at $89.99, BPC-157 10mg at $99.99 and TB-500 10mg at $99.99) would cost $289.97, so the single blended vial is the lowest cost per mg of the three options.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e70mg vial (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg) — $139.99 (about $2.00 per mg)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMulti-vial pricing (70mg):\u003c\/strong\u003e 2 vials $251.98 (10% off, $125.99 each), 3 vials $367.47 (12.5% off, $122.49 each), 4 vials $475.97 (15% off, $118.99 each). The discount is applied automatically in the cart.\u003c\/p\u003e\n\n\u003ch2\u003eQuality and COA verification\u003c\/h2\u003e\n\u003cp\u003eEvery batch of GLOW is independently tested by Janoshik Analytical. HPLC confirms purity, and mass spectrometry confirms the identity of each peptide in the blend by matching its measured mass to the expected molecular weight. A Certificate of Analysis is issued for every batch and published in our \u003ca href=\"\/pages\/certifications-of-analysis\"\u003eCOA library\u003c\/a\u003e, where the batch number printed on your vial can be checked against the report. The blend is lyophilised for long-term stability, sealed in a sterile vial and packed in protective packaging for domestic transit.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently bought together\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/klow\"\u003eKLOW (80mg)\u003c\/a\u003e — $149.99, the same three peptides plus 10mg of KPV for an anti-inflammatory component\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu\"\u003eGHK-Cu (50mg)\u003c\/a\u003e — $89.99, the copper tripeptide on its own for skin and collagen controls\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glow-bundle\"\u003eGLOW Peptide Bundle\u003c\/a\u003e — $189.99, GHK-Cu, BPC-157 and TB-500 supplied as separate vials\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bacteriostatic-water\"\u003eBacteriostatic Water (10mL)\u003c\/a\u003e — $29.99, for reconstituting the lyophilised blend\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch guides\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"\/pages\/ghk-cu-research-guide\"\u003eGHK-Cu research guide\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/pages\/bpc-157-vs-tb-500\"\u003eBPC-157 vs TB-500\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/blogs\/news\/peptide-storage-guide-how-to-store-lyophilised-peptides-properly\"\u003eHow to store lyophilised peptides\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/blogs\/news\/coa-testing-explained-research-peptides-australia\"\u003eCOA testing explained\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/pages\/research-calculator\"\u003ePeptide reconstitution calculator\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/pages\/certifications-of-analysis\"\u003eCertificates of Analysis library\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is GLOW?\u003c\/strong\u003e\u003cbr\u003eGLOW is the product name for a three-peptide research blend supplied as a single 70mg lyophilised vial. The name is coined rather than chemical and reflects the skin and collagen focus of GHK-Cu, its largest component. References to the GLOW peptide, glow blend or glow 70 all mean this specific combination of GHK-Cu, BPC-157 and TB-500 in fixed amounts.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is in the GLOW peptide blend?\u003c\/strong\u003e\u003cbr\u003eEach vial contains 50mg of GHK-Cu, the copper-binding tripeptide glycyl-L-histidyl-L-lysine; 10mg of BPC-157, a pentadecapeptide derived from a gastric protective protein; and 10mg of TB-500, a synthetic peptide based on the actin-binding region of thymosin beta-4. The total is 70mg of peptide, supplied as lyophilised powder in a sealed sterile vial.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is GLOW also known as?\u003c\/strong\u003e\u003cbr\u003eIt is also written as GLOW peptide, glow blend, glow 70 or Glow 70mg, and described as the GHK-Cu BPC-157 TB-500 blend. The components have their own aliases: GHK-Cu is called copper peptide or copper tripeptide-1, BPC-157 is written BPC 157, BPC157 or bcp 157, and TB-500 is written TB500 or described as a thymosin beta-4 fragment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow does GLOW work?\u003c\/strong\u003e\u003cbr\u003eEach component acts differently. GHK-Cu delivers copper to cells, supporting lysyl oxidase-dependent collagen crosslinking and superoxide dismutase activity, and modulates gene expression involved in matrix remodelling. BPC-157 activates VEGFR2 and nitric-oxide signalling and the FAK-paxillin pathway, promoting angiogenesis and fibroblast migration. TB-500 binds G-actin to regulate cytoskeletal remodelling and cell migration. The blend allows these three signals to be studied together in one preparation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat does the research show about GLOW?\u003c\/strong\u003e\u003cbr\u003eGLOW has not been studied as a fixed combination in published trials; the evidence relates to its components. GHK-Cu has been reported to increase collagen and glycosaminoglycan synthesis in fibroblasts and to modulate remodelling genes, BPC-157 has been studied across rodent tendon, muscle and gastrointestinal models, and thymosin beta-4 has reached Phase 2 clinical programmes in dermal wounds and ophthalmic conditions. All three remain investigational research compounds.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I buy GLOW at Chemist Warehouse or a pharmacy in Australia?\u003c\/strong\u003e\u003cbr\u003eNo. GLOW is not a registered medicine and none of its three peptides is stocked by Chemist Warehouse, Priceline or other retail pharmacies. Topical cosmetic serums containing small percentages of GHK-Cu are sold by beauty retailers and some pharmacies, but those are cosmetics; the lyophilised research blend supplied here is a laboratory reagent, not a cosmetic or medicine.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan Australian compounding pharmacies supply GLOW?\u003c\/strong\u003e\u003cbr\u003eCompounding pharmacies in Australia prepare medicines only for an individual patient on a practitioner's prescription and do not sell peptides to the public. Omega Peptides Australia is not a pharmacy. We supply the lyophilised research blend with a batch COA, strictly for in-vitro laboratory use.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow do you reconstitute GLOW?\u003c\/strong\u003e\u003cbr\u003eUse bacteriostatic water. Swab the stopper, then add the chosen volume of water slowly down the inside wall of the vial so it runs onto the powder rather than jetting into it. Swirl gently until the solution is clear, do not shake, because agitation can fragment the peptides. GHK-Cu gives the solution a faint blue tint, which is normal. Label the vial with the date and concentration, refrigerate at 2–8°C and use within 28 days.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow should GLOW be stored?\u003c\/strong\u003e\u003cbr\u003eKeep the lyophilised vial sealed and protected from light and moisture. Short-term storage at 2–8°C is fine; for long-term storage keep it at −20°C and avoid repeated freeze-thaw cycles. After reconstitution, store the solution refrigerated at 2–8°C and use it within 28 days. Let a cold vial reach room temperature before opening it so condensation does not form on the powder.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhere can I buy GLOW in Australia?\u003c\/strong\u003e\u003cbr\u003eDirectly from Omega Peptides Australia. Stock is held domestically, orders placed before 12pm are dispatched the same day, and every batch is tested by Janoshik Analytical with the certificate published in our COA library. GLOW can be ordered on this page or browsed with the rest of our \u003ca href=\"\/collections\/research-peptides-australia\"\u003eresearch peptides in Australia\u003c\/a\u003e, including KLOW, the GLOW Peptide Bundle and the individual GHK-Cu, BPC-157 and TB-500 vials.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat does GLOW cost in Australia?\u003c\/strong\u003e\u003cbr\u003eGLOW is $139.99 for a 70mg vial, or about $2.00 per mg of total peptide. The GLOW Peptide Bundle, which supplies the same three peptides as separate vials, is $189.99, and buying the individual vials would cost $289.97. KLOW, the four-peptide version with KPV, is $149.99 for 80mg.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow do I get GLOW online in Australia?\u003c\/strong\u003e\u003cbr\u003eAdd the 70mg vial to your cart, add bacteriostatic water if required, and complete checkout. Orders ship from within Australia with tracked domestic delivery and discreet, unbranded packaging. Orders placed before 12pm on a business day are dispatched the same day, and later orders leave the next business day.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs GLOW legal in Australia?\u003c\/strong\u003e\u003cbr\u003eOmega Peptides Australia supplies GLOW strictly for lawful in-vitro laboratory research. It is not approved by the TGA for human or veterinary use and is not sold as a medicine or supplement. Purchasers are responsible for ensuring their intended use complies with all applicable laws.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould a laboratory choose the GLOW 70mg vial or the GLOW bundle of separate vials?\u003c\/strong\u003e\u003cbr\u003eChoose the single 70mg vial when the study will use all three peptides together at the fixed 50:10:10 ratio, because it needs one reconstitution and costs less per mg. Choose the \u003ca href=\"\/products\/glow-bundle\"\u003eGLOW Peptide Bundle\u003c\/a\u003e when each compound must be prepared at its own concentration, when single-compound controls are needed. Both are COA-verified.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs GLOW peptide available in Australia?\u003c\/strong\u003e\u003cbr\u003eYes. Omega Peptides Australia holds the GLOW 70mg blend in Australian stock as a research-grade lyophilised vial, COA verified, with same-day dispatch before 12pm.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhere can I buy the GLOW blend in Australia?\u003c\/strong\u003e\u003cbr\u003eFrom an Australian research peptide supplier with domestic stock. Omega Peptides Australia ships GLOW from within Australia on tracked delivery.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat is the tested purity of GLOW?\u003c\/strong\u003e\u003cbr\u003eThe current batch was tested by Janoshik Analytical on 9 July 2026. Individual component batches tested at: GHK-Cu 99.89%, BPC-157 99.66%, TB-500 98.82%. Each report can be checked on Janoshik's verification portal using the batch number, and the certificates are published in \u003ca href=\"\/pages\/certifications-of-analysis\"\u003eour COA library\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e⚠ For in-vitro research and laboratory use only. Not for human or veterinary use.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is GLOW?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"GLOW is the product name for a three-peptide research blend supplied as a single 70mg lyophilised vial. The name is coined rather than chemical and reflects the skin and collagen focus of GHK-Cu, its largest component. References to the GLOW peptide, glow blend or glow 70 all mean this specific combination of GHK-Cu, BPC-157 and TB-500 in fixed amounts.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is in the GLOW peptide blend?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Each vial contains 50mg of GHK-Cu, the copper-binding tripeptide glycyl-L-histidyl-L-lysine; 10mg of BPC-157, a pentadecapeptide derived from a gastric protective protein; and 10mg of TB-500, a synthetic peptide based on the actin-binding region of thymosin beta-4. The total is 70mg of peptide, supplied as lyophilised powder in a sealed sterile vial.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is GLOW also known as?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"It is also written as GLOW peptide, glow blend, glow 70 or Glow 70mg, and described as the GHK-Cu BPC-157 TB-500 blend. The components have their own aliases: GHK-Cu is called copper peptide or copper tripeptide-1, BPC-157 is written BPC 157, BPC157 or bcp 157, and TB-500 is written TB500 or described as a thymosin beta-4 fragment.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How does GLOW work?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Each component acts differently. GHK-Cu delivers copper to cells, supporting lysyl oxidase-dependent collagen crosslinking and superoxide dismutase activity, and modulates gene expression involved in matrix remodelling. BPC-157 activates VEGFR2 and nitric-oxide signalling and the FAK-paxillin pathway, promoting angiogenesis and fibroblast migration. TB-500 binds G-actin to regulate cytoskeletal remodelling and cell migration. The blend allows these three signals to be studied together in one preparation.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What does the research show about GLOW?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"GLOW has not been studied as a fixed combination in published trials; the evidence relates to its components. GHK-Cu has been reported to increase collagen and glycosaminoglycan synthesis in fibroblasts and to modulate remodelling genes, BPC-157 has been studied across rodent tendon, muscle and gastrointestinal models, and thymosin beta-4 has reached Phase 2 clinical programmes in dermal wounds and ophthalmic conditions. All three remain investigational research compounds.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Can I buy GLOW at Chemist Warehouse or a pharmacy in Australia?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"No. GLOW is not a registered medicine and none of its three peptides is stocked by Chemist Warehouse, Priceline or other retail pharmacies. Topical cosmetic serums containing small percentages of GHK-Cu are sold by beauty retailers and some pharmacies, but those are cosmetics; the lyophilised research blend supplied here is a laboratory reagent, not a cosmetic or medicine.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Can Australian compounding pharmacies supply GLOW?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Compounding pharmacies in Australia prepare medicines only for an individual patient on a practitioner's prescription and do not sell peptides to the public. Omega Peptides Australia is not a pharmacy. We supply the lyophilised research blend with a batch COA, strictly for in-vitro laboratory use.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How do you reconstitute GLOW?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Use bacteriostatic water. Swab the stopper, then add the chosen volume of water slowly down the inside wall of the vial so it runs onto the powder rather than jetting into it. Swirl gently until the solution is clear, do not shake, because agitation can fragment the peptides. GHK-Cu gives the solution a faint blue tint, which is normal. Label the vial with the date and concentration, refrigerate at 2-8 degrees Celsius and use within 28 days.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How should GLOW be stored?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Keep the lyophilised vial sealed and protected from light and moisture. Short-term storage at 2-8 degrees Celsius is fine; for long-term storage keep it at −20 degrees Celsius and avoid repeated freeze-thaw cycles. After reconstitution, store the solution refrigerated at 2-8 degrees Celsius and use it within 28 days. Let a cold vial reach room temperature before opening it so condensation does not form on the powder.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy GLOW in Australia?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Directly from Omega Peptides Australia. Stock is held domestically, orders placed before 12pm are dispatched the same day, and every batch is tested by Janoshik Analytical with the certificate published in our COA library. GLOW can be ordered on this page or browsed with the rest of our research peptides in Australia, including KLOW, the GLOW Peptide Bundle and the individual GHK-Cu, BPC-157 and TB-500 vials.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What does GLOW cost in Australia?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"GLOW is $139.99 for a 70mg vial, or about $2.00 per mg of total peptide. The GLOW Peptide Bundle, which supplies the same three peptides as separate vials, is $189.99, and buying the individual vials would cost $289.97. KLOW, the four-peptide version with KPV, is $149.99 for 80mg.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How do I get GLOW online in Australia?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Add the 70mg vial to your cart, add bacteriostatic water if required, and complete checkout. Orders ship from within Australia with tracked domestic delivery and discreet, unbranded packaging. Orders placed before 12pm on a business day are dispatched the same day, and later orders leave the next business day.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is GLOW legal in Australia?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Omega Peptides Australia supplies GLOW strictly for lawful in-vitro laboratory research. It is not approved by the TGA for human or veterinary use and is not sold as a medicine or supplement. Purchasers are responsible for ensuring their intended use complies with all applicable laws.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Should a laboratory choose the GLOW 70mg vial or the GLOW bundle of separate vials?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Choose the single 70mg vial when the study will use all three peptides together at the fixed 50:10:10 ratio, because it needs one reconstitution and costs less per mg. Choose the GLOW Peptide Bundle when each compound must be prepared at its own concentration, when single-compound controls are needed. Both are COA-verified.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is GLOW peptide available in Australia?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes. Omega Peptides Australia holds the GLOW 70mg blend in Australian stock as a research-grade lyophilised vial, COA verified, with same-day dispatch before 12pm.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy the GLOW blend in Australia?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"From an Australian research peptide supplier with domestic stock. Omega Peptides Australia ships GLOW from within Australia on tracked delivery.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is the tested purity of GLOW?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"The current batch was tested by Janoshik Analytical on 9 July 2026. Individual component batches tested at: GHK-Cu 99.89%, BPC-157 99.66%, TB-500 98.82%. Each report can be checked on Janoshik's verification portal using the batch number, and the certificates are published in our COA library.\"\n      }\n    }\n  ]\n}\n\u003c\/script\u003e\n","brand":"Omega Peptides Australia","offers":[{"title":"70mg","offer_id":43208928526398,"sku":"GLOW-70MG","price":139.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0673\/2123\/3470\/files\/Glow_70mg_research_peptide_blend_vial_GHK-Cu_BPC-157_TB-500_Omega_Peptides_Australia.png?v=1787063522","url":"https:\/\/www.omegapeptidesaustralia.com\/products\/glow-70mg-research-peptide-pure-peptides-australia","provider":"Omega Peptides Australia","version":"1.0","type":"link"}